EVH:NYE-Evolent Health Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 29.3

Change

0.00 (0.00)%

Market Cap

N/A

Volume

2.12M

Analyst Target

USD 11.67
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-29 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
SOLV Solventum Corp.

N/A

USD 10.78B
DOCS Doximity Inc

N/A

USD 7.70B
WEAV Weave Communications Inc

N/A

USD 0.89B
AMWL American Well Corp

N/A

USD 0.14B
MPLN MultiPlan Corporation

N/A

USD 0.12B
OWLT Owlet Inc

N/A

USD 0.07B
TDOC Teladoc Inc

N/A

N/A
FOXO FOXO Technologies Inc.

N/A

N/A
PHR Phreesia Inc

N/A

N/A
VEEV Veeva Systems Inc Class A

N/A

N/A

ETFs Containing EVH

EDOC:AU BetaShares Digital Health.. 4.65 % 0.00 %

N/A

N/A
DDOC:XETRA Global X Telemedicine & D.. 4.15 % 0.00 %

N/A

USD 5.39M
DDOC:F Global X Telemedicine & D.. 4.15 % 0.00 %

N/A

USD 4.62M
EDOC:LSE Global X Telemedicine & D.. 3.86 % 0.00 %

N/A

USD 3.87M
EDOG:LSE Global X Telemedicine & D.. 3.86 % 0.00 %

N/A

USD 0.23M
ACTV LeaderShares® Activist L.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -11.29% 20% F 20% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -11.29% 20% F 20% F
Trailing 12 Months  
Capital Gain 7.60% 30% F 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.60% 30% F 37% F
Trailing 5 Years  
Capital Gain 292.76% 100% F 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 292.76% 100% F 93% A
Average Annual (5 Year Horizon)  
Capital Gain 47.27% N/A N/A 94% A
Dividend Return 47.27% N/A N/A 93% A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 71.82% N/A N/A 11% F
Risk Adjusted Return 65.82% N/A N/A 81% B-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike